Prescott Group Capital Management’s Pfizer PFE Stock Holding History

Prescott Group Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-6,324	Closed	-$220K	–	113
2020 Q3	$220K	Buy	+6,324	New	+$222K	0.1%	97
2020 Q1	–	Sell	-6,324	Closed	-$235K	–	139
2019 Q4	$235K	Hold	6,324	–	–	0.08%	125
2019 Q3	$216K	Hold	6,324	–	–	0.07%	141
2019 Q2	$260K	Hold	6,324	–	–	0.06%	142
2019 Q1	$255K	Hold	6,324	–	–	0.05%	153
2018 Q4	$262K	Hold	6,324	–	–	0.05%	188
2018 Q3	$264K	Hold	6,324	–	–	0.05%	191
2018 Q2	$218K	Hold	6,324	–	–	0.04%	202
2018 Q1	$213K	Hold	6,324	–	–	0.05%	185
2017 Q4	$217K	Hold	6,324	–	–	0.05%	169
2017 Q3	$214K	Hold	6,324	–	–	0.04%	152
2017 Q2	$202K	Hold	6,324	–	–	0.04%	157
2017 Q1	$205K	Buy	+6,324	New	+$199K	0.04%	155
2016 Q4	–	Sell	-6,324	Closed	-$203K	–	177
2016 Q3	$203K	Hold	6,324	–	–	0.04%	142
2016 Q2	$211K	Buy	+6,324	New	+$202K	0.05%	137
2015 Q3	–	Sell	-6,324	Closed	-$201K	–	176
2015 Q2	$201K	Hold	6,324	–	–	0.04%	180
2015 Q1	$209K	Buy	+6,324	New	+$201K	0.04%	174

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Prescott Group Capital Management's PFE Position: Q4 2020 in Review

Prescott Group Capital Management sold out of Pfizer (PFE) in Q4 2020, closing a stake of 6,324 shares — an estimated $220K sold.

Prescott Group Capital Management first reported a position in PFE in Q1 2015 and held it in 17 quarters. The position peaked at $264K in Q3 2018. 2,676 funds tracked by Wall St. Rank hold PFE as of Q4 2020.

Prescott Group Capital Management reported no remaining Pfizer position as of Q4 2020 after selling out during the quarter.
Prescott Group Capital Management sold 6,324 Pfizer shares in Q4 2020, an estimated $220K.
Prescott Group Capital Management first reported a position in Pfizer in Q1 2015 and held it in 17 quarters.
Prescott Group Capital Management's Pfizer position peaked at $264K in Q3 2018.
2,676 funds tracked by Wall St. Rank held Pfizer as of Q4 2020.

Based on Prescott Group Capital Management's 13F filing for Q4 2020, filed 10 Feb 2021.